Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-06 4:15 pm |
N/A 2035-01-02 |
Silence Therapeutics plc | SLN | Ede-Golightly James Director |
48,000 | $0 | 48,000 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:15 pm |
N/A 2035-01-02 |
Silence Therapeutics plc | SLN | Davidson Michael H. Director |
48,000 | $0 | 48,000 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:15 pm |
N/A 2035-01-02 |
Silence Therapeutics plc | SLN | Ross Iain Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:15 pm |
N/A 2035-01-02 |
Silence Therapeutics plc | SLN | Lemus David Director |
48,000 | $0 | 48,000 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:15 pm |
N/A 2035-01-02 |
Silence Therapeutics plc | SLN | Romano Steven J. EVP and Chief R&D Officer |
285,000 | $0 | 285,000 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:15 pm |
N/A 2035-01-02 |
Silence Therapeutics plc | SLN | HELLUMS RHONDA LYNETTE Chief Financial Officer |
375,000 | $0 | 375,000 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:15 pm |
N/A 2035-01-02 |
Silence Therapeutics plc | SLN | TOOMAN CRAIG A President and CEO |
900,000 | $0 | 900,000 (Direct) |
View |
Ownership |
2025-01-02 4:43 pm |
N/A N/A |
Silence Therapeutics plc | SLN | Griffiths Richard Ian 10% Owner |
0 | $0 | 27,266,001 (Indirect) |
View |
Ownership |
2025-01-02 4:39 pm |
N/A N/A |
Silence Therapeutics plc | SLN | TOOMAN CRAIG A President and CEO |
0 | $0 | 5,121,325 (Direct) |
View |
Ownership |
2025-01-02 4:38 pm |
N/A N/A |
Silence Therapeutics plc | SLN | Ross Iain Director |
0 | $0 | 1,309,942 (Direct) |
View |
Ownership |
2025-01-02 4:36 pm |
N/A N/A |
Silence Therapeutics plc | SLN | Ede-Golightly James Director |
0 | $0 | 159,000 (Direct) |
View |
Ownership |
2025-01-02 4:34 pm |
N/A N/A |
Silence Therapeutics plc | SLN | Davidson Michael H. Director |
0 | $0 | 156,993 (Direct) |
View |
Ownership |
2025-01-02 4:32 pm |
N/A N/A |
Silence Therapeutics plc | SLN | HELLUMS RHONDA LYNETTE Chief Financial Officer |
0 | $0 | 1,575,522 (Direct) |
View |
Ownership |
2025-01-02 4:29 pm |
N/A N/A |
Silence Therapeutics plc | SLN | Lemus David Director |
0 | $0 | 151,527 (Direct) |
View |
Ownership |
2025-01-02 4:26 pm |
N/A N/A |
Silence Therapeutics plc | SLN | Romano Steven J. EVP and Chief R&D Officer |
0 | $0 | 1,083,993 (Direct) |
View |